News

Filter

Current filters:

None

1 to 9 of 97848 results

EC approves Zambon and Newron’s Xadago for late-stage PD patients

EC approves Zambon and Newron’s Xadago for late-stage PD patients

27-02-2015

Zambon and its partner, fellow Italy-based Newron Pharmaceuticals, have received approval from the European…

EuropeNeurologicalNewron PharmaceuticalsPharmaceuticalRegulationXadagoZambon

Amgen and Onyx’s MAA for Kyprolis is accepted by EMA

Amgen and Onyx’s MAA for Kyprolis is accepted by EMA

27-02-2015

The European Medicines Agency has accepted the Marketing Authorization Application for Kyprolis (carfilzomib)…

AmgenEuropeKyprolisOncologyOnyx PharmaceuticalsPharmaceuticalRegulation

BIA welcomes UK’s R&D tax credit scheme

BIA welcomes UK’s R&D tax credit scheme

27-02-2015

The UK BioIndustry Association (BIA) is calling for an extended advance assurance scheme in its response…

FinancialPharmaceuticalUKUK BioIndustry AssociationUnited Kingdom

Chiesi found to have breached ABPI Code

Chiesi found to have breached ABPI Code

27-02-2015

Privately-held Italian drugmaker Chiesi Farmaceutici has been publicly reprimanded for providing inaccurate…

Chiesi FarmaceuticiFostairLegalPharmaceuticalRegulationUK

Synthetic biology breakthrough leads to cheaper statin production

27-02-2015

University of Manchester researchers, together with industrial partner, Dutch biotech company DSM, have…

Cardio-vascularGenericsProduction

2015 outlook for US and EU pharma; report

2015 outlook for US and EU pharma; report

27-02-2015

According to this Global Pharma US & EU Outlook 2015 report, strategy diversification stays divested…

EuropeManagementMarkets & MarketingMergers & AcquisitionsPatentsPharmaceuticalUSA

2014 a record year for Bayer, with pharma fired up by new products

2014 a record year for Bayer, with pharma fired up by new products

27-02-2015

For German pharma major Bayer, 2014 proved to be a record year, with the company notching up sales of…

BayerFinancialGermanyManagementMarijn DekkersPharmaceutical

Report: Japanese pharma market edging towards $80 Billion by 2020

Report: Japanese pharma market edging towards $80 Billion by 2020

26-02-2015

Japan’s pharmaceutical market value is set to grow at a tepid Compound Annual Growth Rate (CAGR) of…

Bristol-Myers SquibbGlobalDataJapanMarkets & MarketingPharmaceutical

1 to 9 of 97848 results

COMPANY SPOTLIGHT

Menarini

Back to top